anti-Pseudomonas sp. antibody product blog
Tags: Antibody; Polyclonal Antibody; Pseudomonas sp.; anti-Pseudomonas sp. antibody;
The Pseudomonas sp. n/a (Catalog #MBS324163) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Pseudomonas sp. can be used in a range of immunoassay formats including, but not limited to, Immunofluorescence.Titer: > 1:800 by indirect immunofluorescence. Researchers should empirically determine the suitability of the Pseudomonas sp. n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
This product consists of the purified IgG fraction of the above antiserum prepared by methods developed by ViroStat to a purity of >95%. The product is formulated in a phosphate saline buffer (0.01M, pH 7.2) containing 0.1% sodium azide preservative. No stabilizing proteins have been added. Potential applications for this product are numerous including ELISA, fluorescence microscopy, immunoblotting and immunohistochemistry. In addition, this product may be used in place of neat antiserum in almost any appropriate antibody-based technique. It is also suitable for conjugation purposes. Protein concentration is 4-5 mg/ml. Recommended short term (<6 months) storage is liquid at 2-8 degree C. For longer term storage, store at -20 degree C to -70 degree C, aliquot and freeze. Unit size is 1.0 ml.
Immunogen: whole cells of Pseudomonas aeruginosa, ATCC #27853
Reactivity Note: Antiserum is not absorbed and may crossreact with related microorganisms. Antiserum Characterization: (neat). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Pseudomonas sp. are readily searchable from our website. Different antibodies against the same target such as Pseudomonas sp. may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.